Inappropriate use of progression-free survival in cancer drug approvals

Research output: Contribution to journal › Editorial › peer-review

8 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{94d5babaf93a491dbc3ec9ec9adfd408,

title = "Inappropriate use of progression-free survival in cancer drug approvals",

author = "Huseyin Naci and Courtney Davis",

year = "2020",

month = mar,

day = "10",

doi = "10.1136/bmj.m770",

language = "English",

volume = "368",

pages = "m770",

journal = "BMJ (Clinical research ed.)",

issn = "0959-8146",

}

TY - JOUR

T1 - Inappropriate use of progression-free survival in cancer drug approvals

AU - Naci, Huseyin

AU - Davis, Courtney

PY - 2020/3/10

Y1 - 2020/3/10

UR - http://www.scopus.com/inward/record.url?scp=85081671463&partnerID=8YFLogxK

U2 - 10.1136/bmj.m770

DO - 10.1136/bmj.m770

M3 - Editorial

C2 - 32156802

SN - 0959-8146

VL - 368

SP - m770

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

ER -